DPIIT recognised startup Government of India
Startup India
Biozenta Lifescience Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹54.72 Cr
▲ 69% YoY
Net profit · FY 2024
₹7.47 Cr
Net margin 13.6%
EBITDA · FY 2024
₹14.53 Cr
EBITDA margin 26.5%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹60 Lakh
Issued & subscribed
Open charges
₹23.02 Cr
Satisfied ₹3 Cr
Company age
8 yrs
Est. 2018
Employees · EPFO
55
Provident fund records
About Biozenta Lifescience Private Limited
Data last updated:
Biozenta Lifescience Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 22 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC440022. Its GSTIN is 05AAHCB6665Q1Z0 (Uttarakhand). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹60 Lakh. It is led by directors including Deep Narayan (Managing Director) and Babita Saini.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹54.72 Cr, a growth of 69% compared to the previous year. For the same year it recorded a net profit of ₹7.47 Cr (net margin 13.6%) and EBITDA of ₹14.53 Cr (EBITDA margin 26.5%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 86% over five years.
The company has about 55 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Biozenta Lifescience. As per MCA filings, the company has open charges of ₹23.02 Cr and satisfied charges of ₹3 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending. The company has 2 deals on record (2 funding rounds), with disclosed funding of ₹59 Lakh; the latest was in May 2022. Its 10 peer companies in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Crosol Crop Care Private Limited with revenue of ₹54.9 Cr.
Biozenta Lifescience Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-12-0000172). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biozenta.com.
Company details
CIN U74999MH2018PTC440022
Registration Number 440022
Incorporation Date 22 February 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Medium
Udyam Registration UDYAM-HP-12-0000172
CIN history
Biozenta Lifescience has one previous CIN (Corporate Identification Number): U74999UR2018PTC008482. The current CIN is U74999MH2018PTC440022, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999MH2018PTC440022 | Current |
| U74999UR2018PTC008482 | Previous |
Recognitions & Rankings of Biozenta Lifescience
MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-HP-12-0000172
Contact details
Biozenta Lifescience Private Limited's registered office is in Mumbai, Maharashtra. Its website is biozenta.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address# 7/54 Building No. 7 Anand Nagar Sahayog, Cooperative Housing Society Ltd Nehru Road, Mumbai, Maharashtra, India – 400055
- IndustryHealthcare, Medical Consumables & Supplies
To see the full contact details of Biozenta Lifescience Private Limited, buy the company report.
Comprehensive company report
Biozenta Lifescience Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Biozenta Lifescience operates one associated brand: Biozenta Lifescience. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Functions as a diversified pharmaceutical company developing and supplying various medications. | biozenta.com |
Business activity
The main business activity of Biozenta Lifescience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Biozenta Lifescience Private Limited, buy the company report.
Financials of Biozenta Lifescience Private Limited
FY 2024 filings availableBiozenta Lifescience Private Limited reported revenue of ₹54.72 Cr (up 69% YoY) for FY 2024.
Revenue · FY 2024
₹54.72 Cr ▲ 69%
Net profit · FY 2024
₹7.47 Cr margin 13.6%
EBITDA · FY 2024
₹14.53 Cr margin 26.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 69%
3 years · compounded
▲ 4%
5 years · compounded
▲ 86%
EBITDA CAGR growth
1 year
▲ 263%
3 years · compounded
▲ 13%
5 years · compounded
▲ 152%
Revenue has grown at a compounded annual rate (CAGR) of 86% over five years, including 69% growth in the latest year. EBITDA rose 263% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹54.72 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.53 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.47 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 26.5% | ||||
| Net Profit Margin | 13.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biozenta Lifescience Private Limited, buy the company report.
Board of directors of Biozenta Lifescience Private Limited
Biozenta Lifescience has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Babita Saini | Director | 19 Jan 2024 | 2 Years 9 Months | Current |
| Abhishek Jain | Director | 19 Jan 2024 | 2 Years 9 Months | Current |
| Subodh Saini Also directs: Dadmik Industries Private Limited | Director | 19 Jan 2024 | 2 Years 9 Months | Current |
| Jainendra Kumar Sahu | Director | 02 May 2024 | 2 Years 5 Months | Current |
| Deep Narayan Also directs: Novric Research and Services LLP, Dadmik Industries Private Limited, Biozenta Farmacia Private Limited and 2 more | Managing Director | 22 Feb 2018 | 8 Years 8 Months | Current |
| Sushil Kumar | Director | 17 Jun 2025 | 1 Years 4 Months | Current |
Peer comparison
Biozenta Lifescience Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Crosol Crop Care Private Limited | ₹54.9 Cr (FY 2016) | 539.0% | Warangal, Telangana, India | |||
| Advatech Cera Tiles Limited | ₹54.9 Cr (FY 2025) | 4.0% | Mehsana, Gujarat, India | |||
| G Amphray Pharmaceuticals Private Limited | ₹54.89 Cr (FY 2025) | 13.0% | Mumbai, Maharashtra, India | |||
| Kamla Lifesciences Limited | ₹54.89 Cr (FY 2024) | 115.0% | Boisar, Maharashtra, India | |||
| Medishare Private Limited | ₹54.81 Cr (FY 2025) | 28.0% | Delhi, India | |||
| Biozenta Lifescience Private Limitedthis company | ₹54.72 Cr (FY 2024) | ₹7.47 Cr | 13.6% | 69.0% | 55 | Mumbai, Maharashtra, India |
| Prasad Organics Private Limited | ₹54.68 Cr (FY 2025) | 25.0% | Chennai, Tamil Nadu, India | |||
| Shatabdi Chemicals Private Limited | ₹54.67 Cr (FY 2024) | -14.0% | Delhi, India | |||
| Vadivel Pyrotechs Private Limited | ₹54.63 Cr (FY 2024) | 43.0% | Sivakasi, Tamil Nadu, India | |||
| Jemby Chem Limited | ₹54.6 Cr (FY 2024) | 33.0% | Ahmedabad, Gujarat, India | |||
| Chemisol India Pvt.Ltd. | ₹54.58 Cr (FY 2024) | 18.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Biozenta Lifescience Private Limited, buy the company report.
Auditor
Biozenta Lifescience Private Limited is audited by CHETAL VIKESH & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHETAL VIKESH & ASSOCIATES | FY 2024 | 016749N |
Shareholding
The shareholding of Biozenta Lifescience Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Biozenta Lifescience Private Limited, buy the company report.
Charges & borrowings
Open charges
₹23.02 Cr
Satisfied charges
₹3 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Oct 2025 | 101182986 | Canara Bank | ₹28.95 Lakh | Open | |
| 11 Mar 2025 | 101059565 | Sidbi | ₹1 Cr | Open | |
| 11 Mar 2025 | 101060150 | Sidbi | ₹10 Cr | Open | |
| 30 Jan 2025 | 101049607 | Canara Bank | ₹9.75 Lakh | Open | |
| 19 Nov 2022 | 100654062 | Canara Bank | ₹34 Lakh | Open |
To see the full charge records of Biozenta Lifescience Private Limited, buy the company report.
Total charge records: 12 View all charges
Deals & funding
Biozenta Lifescience Private Limited has 2 deals on record (2 funding rounds), with disclosed funding of ₹59 Lakh; the latest was in May 2022.
Total deals
2
Funding rounds
2
Disclosed funding
₹59 Lakh
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2022 | Funding round | ₹20 Lakh | Investors: 2 individuals |
| Mar 2020 | Funding round | ₹39 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Biozenta Lifescience Private Limited has 1 court case on record: 1 filed by Biozenta Lifescience. All case is pending.
Total cases
1
Filed by the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Una, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against M/S Sapruhaa Health Care Pvt Ltd | Pending |
To see the full case history of Biozenta Lifescience Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Biozenta Lifescience Private Limited was last rated by Brickwork on 20 Aug 2019.
| Rating agency | Rated on | Rating |
|---|---|---|
| Brickwork | 20 Aug 2019 |
To see the full credit ratings and regulatory alerts of Biozenta Lifescience Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biozenta Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Biozenta Lifescience Private Limited has a workforce of 55 employees on its EPFO records as of Mar 31, 2025, across 1 active EPFO establishment.
Employee count
55
Active EPFO establishments
1
Employee growth
30.95%
GST
Biozenta Lifescience has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAHCB6665Q1Z0 | Uttarakhand | Active | 20 Mar 2018 |
| 02AAHCB6665Q1Z6 | Himachal Pradesh | Active | 18 Apr 2019 |
| 03AAHCB6665Q1Z4 | Punjab | Active | 01 Jan 2022 |
To see the full GST registrations and return filing status of Biozenta Lifescience Private Limited, buy the company report.
Recent activity
Biozenta Lifescience Private Limited has 8 board changes on record since 2018: 6 appointments and 2 cessations. The latest: Sushil Kumar was appointed as Director on 17 Jun 2025.
Charges
A charge with Canara Bank amounted to Rs. 0.29 Cr with Charge ID 101182986 was registered on 15 Oct 2025.
Appointed
Sushil Kumar was appointed as Director.
Charges
A charge with Sidbi amounted to Rs. 1.00 Cr with Charge ID 101059565 was registered on 11 Mar 2025.
Charges
A charge with Sidbi amounted to Rs. 10.00 Cr with Charge ID 101060150 was registered on 11 Mar 2025.
Charges
A charge with Canara Bank amounted to Rs. 0.10 Cr with Charge ID 101049607 was registered on 30 Jan 2025.
AGM
Biozenta Lifescience Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Appointed
Jainendra Kumar Sahu was appointed as Director.
Filing
Biozenta Lifescience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Appointed
Abhishek Jain was appointed as Director.
Appointed
Babita Saini was appointed as Director.
Ceased
Reeta Devi ceased to be Director.
Appointed
Subodh Saini was appointed as Director.
14 earlier events are in the company report.
Frequently asked questions
Biozenta Lifescience is an active private limited company based in Mumbai, Maharashtra, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 22 February 2018 (8+ years old) and is registered under CIN U74999MH2018PTC440022.
Biozenta Lifescience has 6 current directors:
- Deep Narayan - Managing Director
- Babita Saini - Director
- Abhishek Jain - Director
- Subodh Saini - Director
- Jainendra Kumar Sahu - Director
- Sushil Kumar - Director
The latest financial statements of Biozenta Lifescience on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Biozenta Lifescience is 05AAHCB6665Q1Z0, registered in Uttarakhand. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 02AAHCB6665Q1Z6 (Himachal Pradesh), 03AAHCB6665Q1Z4 (Punjab).
The CIN (Corporate Identification Number) of Biozenta Lifescience is U74999MH2018PTC440022. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biozenta Lifescience has 1 court case on record: 1 filed by the company. 1 is pending.
Biozenta Lifescience was incorporated on 22 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Biozenta Lifescience has 2 deals on record (2 funding rounds), with disclosed funding of ₹59 Lakh; the latest was in May 2022.
The peers of Biozenta Lifescience by revenue are Crosol Crop Care Private Limited, Advatech Cera Tiles Limited, G Amphray Pharmaceuticals Private Limited, Kamla Lifesciences Limited, Medishare Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sushil Kumar was appointed as Director on 17 Jun 2025. Jainendra Kumar Sahu was appointed as Director on 02 May 2024. Abhishek Jain was appointed as Director on 19 Jan 2024. Biozenta Lifescience has 8 board changes on record in total.
Yes, Biozenta Lifescience is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).